• 
• http://www.moleculartherapy.org
• Editor: David A. Williams, MD
• Volume 16: 12 issues per year
• ISSN: 1525-0016
• Impact factor : 5.862*
• Impact ranking: 7/81 in Medicine, Research & Experimental; 17/132 in Genetics & Heredity; 8/138 in Biotechnology & Applied Microbiology*
• Date Established: January 2000
• Published on behalf of: Official journal of the American Society of Gene Therapy

Aims and Scope:

Molecular Therapy publishes peer-reviewed original studies in the emerging field of molecular therapies to treat human diseases. The journal welcomes outstanding contributions in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide- and protein-, oligonucleotide- and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trails. The journal encompasses therapeutics from emerging stem cell technology to small molecules, with a focus on both viral and non-viral vector development and applications.

Readership:

Molecular Therapy is read by researchers, translational scientists and physicians interested in the latest advances in cell and gene therapy and new innovations in all aspects of molecular approaches to treating human diseases. The journal is also of interest to the broad range of institutional and governmental administrators involved in regulatory oversight of these therapies.

Molecular Therapy provides (sections are):

• Original Articles - Investigational studies presenting:
• basic and preclinical studies applying gene therapy or other molecular medicine interventions to specific disease models or biological problems
• studies aimed at establishing proof-of-principle for novel therapeutic approaches
• studies defining new methodological tools or improving established methods
• reports on the results of human clinical trials of gene therapy and other molecular medicine approaches to disease.
• Review Articles - Written by recognized experts on the subject, reviews not only outline the "state of the art," but also try to project future directions.
• Commentaries - Short descriptions and analyses of important research published in Molecular Therapy or elsewhere, events in gene therapy, or social, ethical or political issues of interest to Molecular Therapy readers.
• Letters to the Editor - Succinct statements or opinions responding to articles published in Molecular Therapy or commenting on events that have an impact on the gene therapy community as a whole.

What makes Molecular Therapy stand apart?

• Comprehensive Research - the journal publishes high-quality, peer-reviewed original research from leading researchers in fields ranging from genetics, medicine and biotechnology - covering all aspects of gene therapy.
• Unparalleled Breadth and Depth - Molecular Therapy is the only journal that can boast being ranked within the top 8th percentile in both Medicine, Research & Experimental and Biotechnology & Applied Microbiology subject areas*.
• Global Coverage - the journal is international in scope and publication.
• Accessibility to a Broad Readership - articles published in Molecular Therapy are accompanied by supplementary information in the form of text, figures or videos. This allows readers to tailor information to suit their individual needs.
• Unique Online Features - selected articles are published online in advance of appearing in the print version, providing immediate access to the latest research.
• Advanced User Functionality - the clean design of the journal's website facilitates easy navigation and retrieval of information for users.

Online features and site license access:

• Online archive available back to 2000.
• A site license provides access to all content published during the supply period. Archive content is freely available after 12 months.
• Users have access to all the online features of nature.com. Find out more >>
• Site license customers will benefit from the services available. Find out more >>
• Indexed in AIDS Abstracts, BIOBASE, Biotechnology Citation Index, Chemical Abstract, Current Contents, Excerpta Medica, Abstract Journals, Inpharma Weekly, Medline (PubMed), Pharmacogenomics and Outcomes News, Reactions Weekly, EMBASE, EMBiology and Scopus.

*2007 Journal Citation Report (Thomson Reuters, 2008)